Current treatment options for systemic lupus erythematosus ... and a few biologics, approved or of 'off-label'. Through judicious use of these currently available medications it is clear that ...
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years. The European Commission has ...
After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline ...
The main safety considerations with this drug are hypertension and worsening renal function. Over the past decade mycophenolate mofetil (MMF) has become one of the most studied drugs for lupus ...